BIO-B
BIO-RAD LABORATORIES, INC.
Key Financials
Net Income
$759.9M
↑ 141.2%
Gross Profit
$1.3B
↓ 2.8%
Revenue
$2.6B
↑ 0.7%
EPS (Diluted)
$27.85
↑ 142.6%
Total Assets
$10.6B
↑ 12.9%
Shareholders' Equity
$7.5B
↑ 13.5%
Cash & Equivalents
$529.8M
↑ 8.5%
Operating Income
$47.2M
↓ 82.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 5/28/2026 | View on SEC |
| SD | 5/13/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 144 | 5/11/2026 | View on SEC |
| S-8 | 4/30/2026 | View on SEC |
| 10-Q | 4/30/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| 4 | 4/28/2026 | View on SEC |
| 4 | 4/28/2026 | View on SEC |
| 8-K | 4/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BIO-B |
| Company Name | BIO-RAD LABORATORIES, INC. |
| CIK | 12208 |
| Sector | Laboratory Analytical Instruments |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 5107247000 |